Literature DB >> 15115524

Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.

A Karim, F Lawlor, M M Black.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15115524     DOI： 10.1111/j.1365-2230.2004.01518.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  5 in total

Review 1.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 2.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

3.  [Scleromyxedema].

Authors:  G Kukova; D Bruch-Gerharz; K Gensch; T Ruzicka; J Reifenberger
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

4.  [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin].

Authors:  S Topf; M Simon; H Schell; M Lüftl
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

5.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.